Abstract
dc:descriptionWe are reporting our experience on patients with pelvic Ewing’s Sarcoma treated in the Royal Orthopaedic Oncology Unit. We retrospectively reviewed a series of patients with non-metastatic pelvic Ewing’s sarcoma treated between 1977 and 2009. Patients were classified into three groups according to the local treatment received: Group 1: Radiotherapy-chemothrapy; Group 2: Surgery-chemotherapy and Group 3: Radiotherapy-surgery-chemotherapy. Recurrence free and overall survival rates were calculated using the Kaplan-Meier method. Influence of various factors (age at diagnosis, gender, tumour site and size, chemotherapy response, surgical margins and type of treatment) on survival was assessed with a logistic regression model. A total of 85 patients were treated with a mean follow-up of 65.8 months and mean tumour volume of 435ml. The 5-year survival for all patients was 40.7% decreased to 36.2% at 10 years. A significant prognostic factor identified was chemotherapy response only. There was a trend for improved survival and local control rates for patients who had chemotherapy and surgery and the results were apparent for all tumours irrespective of size but not statistically significant. Currently, the optimal management of pelvic Ewing’s sarcoma is controversial but our study shows a trend for improved survival for patients treated with chemotherapy and surgery.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dramis, Asterios
- Δράμης, Αστέριος
Subjects
dc:subject × 18- Ewing σάρκωμα
- Πύελος
- Χειρουργική επέμβαση
- Ακτινοθεραπεία
- Προγνωστικοί παράγοντες
- Χημειοθεραπεία
- Ογκολογικά αποτελέσματα
- Ewing Sarcoma
- Pelvis
- Surgery
- Radiotherapy
- Chemotherapy
- Prognostic factors
- Oncological Outcomes
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38335